Peripartum CM Ups Future Pregnancy Risks Despite LV Recovery at AshTip Solution.

VIENNA — Resolution of non-alcoholic steatohepatitis (NASH), and reduction of fibrosis on liver biopsy were achieved with the oral, thyroid hormone receptor beta-selective agonist resmetirom (Madrigal Pharmaceuticals) in patients with NASH and associated cirrhosis in a pivotal phase 3 clinical trial. The primary results of the MAESTRO-NASH (NCT03900429) trial were reported here at the European Association for the Study of the Liver (EASL) Congress 2023. 2023-06-22

CHICAGO – Treatment of hyperthyroidism with surgery or radioactive iodine significantly extends survival compared to antithyroid medication, while surgery raises the risk for obesity, new data from a large cohort study suggest. 2023-06-25

Family physicians are the only providers of care for most patients with several chronic diseases, according to new research. 2023-07-03

Multiple gut bacterial species that are commonly found in the mouth, especially several forms of Streptococcus, were associated with coronary atherosclerosis and systemic inflammatory biomarkers in a population-based observational study. 2023-07-19

Women in the US are dying of alcohol-related causes at a much faster rate than are US men, according to a new study that tracked these deaths for 20 years. The most dramatic rise occurred in the last 3 years covered by the study. 2023-07-28